CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
ACRYSOF IQ PanOptix Toric Trifocal IOL +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04542525
NCT04542525N/ACompleted
CompareCT.gov

Clinical Investigation of AcrySof IQ PanOptix Toric Intraocular Lens Model TFNT20

Alcon Research·interventional·Posted Sep 9, 2020·Updated Aug 17, 2022

In Brief

A clinical study evaluating ACRYSOF IQ PanOptix Toric Trifocal IOL and Cataract surgery for Aphakia and Corneal Astigmatism. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the effectiveness and safety of the TFNT20 low cylinder power intraocular lens when implanted in the eye to replace the natural lens following cataract removal.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAphakia, Corneal Astigmatism
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 9, 2020
Enrollment StartDec 1, 2020
Primary CompletionAug 10, 2021
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 5.8 years ago

Interventions

ACRYSOF IQ PanOptix Toric Trifocal IOLdevice

Single-piece, ultraviolet and blue-light filtering, foldable, multifocal toric IOL intended to provide vision to aphakic subjects at near, intermediate, and distance and to correct pre-existing corneal astigmatism

Cataract surgeryprocedure

Cataract extraction by phacoemulsification, followed by implantation of the IOL per investigator's standard of care and instructions for use